Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-10-07, the close was $15.17: 8.1% below the 50-day average and 8.6% below the 200-day average, which is falling. RSI (14) is 34, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 15% of the way up its 52-week range of $14.49 to $18.90, on 0.9x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $16.51 | Price 8.1% below |
| 200-day average | $16.59 | Price 8.6% below, average falling |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 34 | Neutral range |
| MACD (12, 26, 9) | -0.39 vs -0.40 | Bullish cross in the last 10 days |
| 52-week range | $14.49 to $18.90 | 15% of the way up the range |
| Volume vs 20-day average | 0.9x | Normal |
Base rates use HBAN's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-07, HBAN's 14-day RSI is 34, which is in the neutral range between 30 and 70.
No. HBAN closed at $15.17 on 2026-10-07, 8.6% below its 200-day average of $16.59, which is falling. When it closed below its 200-day average (2,296 days), it was higher 63 trading days later 63% of the time, median +5.2%.
No. HBAN closed at $15.17 on 2026-10-07, 8.1% below its 50-day average of $16.51. When it closed below its 50-day average (2,826 days), it was higher 63 trading days later 63% of the time, median +3.8%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-07 the MACD line is -0.39 against a signal line of -0.40, so MACD is bullish.
No. At $15.17 it sits 15% of the way up its 52-week range of $14.49 to $18.90, 19.7% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-10-07 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: S-Buy, from the chart signal model.
HBAN analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.